Engineered fusion molecules immunotherapy in cancer and inflammatory diseases

Details for Australian Patent Application No. 2009223784 (hide)

Owner Immungene, Inc.

Inventors Khare, Sanjay D.

Agent Shelston IP

Pub. Number AU-A-2009223784

PCT Pub. Number WO2009/114110

Priority 61/068,628 08.03.08 US

Filing date 7 March 2009

Wipo publication date 17 September 2009

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/114110 Priority application(s): WO2009/114110

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223793-A beverage cartridge

2009223780-Overburden removal system with triple track mobile sizer